Emergent BioSolutions (EBS) Shareholder's Equity (2010 - 2026)
Emergent BioSolutions (EBS) Shareholder's Equity (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Emergent BioSolutions | 415.46 Mn | 253.96 Mn | 84.10 Mn | 523.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 523.10 Mn |
| Dec 31, 2025 | 522.60 Mn |
| Sep 30, 2025 | 582.50 Mn |
| Jun 30, 2025 | 536.20 Mn |
| Mar 31, 2025 | 552.70 Mn |
| Dec 31, 2024 | 482.80 Mn |
| Sep 30, 2024 | 508.40 Mn |
| Jun 30, 2024 | 386.30 Mn |
| Mar 31, 2024 | 663.90 Mn |
| Dec 31, 2023 | 649.30 Mn |
| Sep 30, 2023 | 697.20 Mn |
| Jun 30, 2023 | 957.70 Mn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.39 Bn |
| Sep 30, 2022 | 1.43 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.61 Bn |
| Sep 30, 2021 | 1.52 Bn |
| Jun 30, 2021 | 1.54 Bn |